Approval · Notice of Compliance 29243 · 2022
ZOLOFT: Notice of Compliance 29243
Issued October 19, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29243
- Date
- October 19, 2022
- Company
- Upjohn Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Drug Interactions and PMI sections of the Product Monograph (PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLOFT | Not yet assigned | — |
Medicinal ingredients
- SERTRALINE HYDROCHLORIDE 25 MG per CAP
- SERTRALINE HYDROCHLORIDE 50 MG per CAP
- SERTRALINE HYDROCHLORIDE 100 MG per CAP